Franklin Resources
CYTK icon

Franklin Resources’s Cytokinetics CYTK Stock Holding History

Franklin Resources’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.9M Buy
891,087
+481,303
+117% +$34.6M 0.02% 553
2026
Q1 		$27M Sell
409,784
-206
-0.1% -$13.1K 0.01% 868
2025
Q4 		$26.1M Buy
409,990
+265
+0.1% +$16.5K 0.01% 869
2025
Q3 		$22.5M Buy
409,725
+6,936
+2% +$286K 0.01% 915
2025
Q2 		$13.3M Sell
402,789
-134,835
-25% -$4.69M ﹤0.01% 1043
2025
Q1 		$21.6M Sell
537,624
-8,189
-2% -$376K 0.01% 882
2024
Q4 		$25.7M Buy
545,813
+9,366
+2% +$486K 0.01% 826
2024
Q3 		$29.2M Buy
536,447
+132,886
+33% +$7.41M 0.01% 769
2024
Q2 		$21.9M Sell
403,561
-161,735
-29% -$9.76M 0.01% 828
2024
Q1 		$39.6M Sell
565,296
-95,386
-14% -$7.38M 0.01% 645
2023
Q4 		$55.2M Sell
660,682
-470,406
-42% -$17M 0.03% 472
2023
Q3 		$33.3M Buy
1,131,088
+10,903
+1% +$363K 0.02% 609
2023
Q2 		$36.5M Buy
1,120,185
+35,541
+3% +$1.31M 0.02% 614
2023
Q1 		$38.2M Sell
1,084,644
-21,396
-2% -$873K 0.02% 612
2022
Q4 		$50.7M Sell
1,106,040
-2,232
-0.2% -$96K 0.03% 526
2022
Q3 		$53.7M Buy
1,108,272
+14,692
+1% +$707K 0.03% 499
2022
Q2 		$43M Buy
1,093,580
+1,708
+0.2% +$68.8K 0.02% 583
2022
Q1 		$40.2M Buy
1,091,872
+52,799
+5% +$1.88M 0.02% 659
2021
Q4 		$47.4M Buy
1,039,073
+39,026
+4% +$1.51M 0.02% 651
2021
Q3 		$35.7M Buy
+1,000,047
New +$29.4M 0.01% 748

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources's CYTK Position: Q2 2026 in Review

Franklin Resources increased its Cytokinetics (CYTK) stake by 117% in Q2 2026, buying an estimated $34.6M and bringing the position to 891,087 shares worth $75.9M. The position accounts for 0.02% of the portfolio, ranked #553.

Franklin Resources first reported a position in CYTK in Q3 2021 and has held it in 20 quarters since. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Franklin Resources held 891,087 shares of Cytokinetics worth $75.9M as of Q2 2026.
  • Franklin Resources bought 481,303 Cytokinetics shares in Q2 2026, an estimated $34.6M.
  • Cytokinetics made up 0.02% of Franklin Resources's portfolio in Q2 2026, its #553 holding.
  • Franklin Resources first reported a position in Cytokinetics in Q3 2021 and has held it in 20 quarters since.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.